ID   KBH5.0
AC   CVCL_D644
DR   BTO; BTO:0005296
DR   Wikidata; Q54899581
RX   PubMed=14679002;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:51232; 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole (Hoechst 33342; Hoe 33342).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
RX   PubMed=14679002;
RA   Li T.-K., Houghton P.J., Desai S.D., Daroui P., Liu A.A., Hars E.S.,
RA   Ruchelman A.L., LaVoie E.J., Liu L.F.;
RT   "Characterization of ARC-111 as a novel topoisomerase I-targeting
RT   anticancer drug.";
RL   Cancer Res. 63:8400-8407(2003).